the above titled paper examined the food and drug administration’s (fda’s) warning letters and notice of violations (nov) over a 10-year period. findings from this content analysis reinforced what has been the primary issue for prescription direct-to-consumer advertising (dtca) since its beginning, the fair balance of risk and benefit information. as opposed to another analysis in 2026 about th...

background for the purpose of understanding the food and drug administration’s (fda’s) concerns regarding online promotion of prescription drugs advertised directly to consumers, this study examines notices of violations (novs) and warning letters issued by the fda to pharmaceutical manufacturers.   methods the fda’s warning letters and novs, which were issued to pharmaceutical companies over a...

0